These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34546648)

  • 1. Updates to the Spectrum/AIM model for the UNAIDS 2020 HIV estimates.
    Stover J; Glaubius R; Kassanjee R; Dugdale CM
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25778. PubMed ID: 34546648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels.
    Stover J; Glaubius R; Mofenson L; Dugdale CM; Davies MA; Patten G; Yiannoutsos C
    AIDS; 2019 Dec; 33 Suppl 3(Suppl 3):S227-S234. PubMed ID: 31805028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children.
    Stover J; Brown T; Marston M
    Sex Transm Infect; 2012 Dec; 88 Suppl 2(Suppl_2):i11-6. PubMed ID: 23172341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates to the spectrum model to estimate key HIV indicators for adults and children.
    Stover J; Andreev K; Slaymaker E; Gopalappa C; Sabin K; Velasquez C; Nakiyingi-Miiro J; Crampin A; Lutalo T; Herbst K; Gregson S; Urassa M
    AIDS; 2014 Nov; 28 Suppl 4(4):S427-34. PubMed ID: 25406748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package.
    Stover J; Walker N; Grassly NC; Marston M
    Sex Transm Infect; 2006 Jun; 82 Suppl 3(Suppl 3):iii45-50. PubMed ID: 16735293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.
    GBD 2015 HIV Collaborators
    Lancet HIV; 2016 Aug; 3(8):e361-e387. PubMed ID: 27470028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
    Kassanjee R; Johnson LF; Zaniewski E; Ballif M; Christ B; Yiannoutsos CT; Nyakato P; Desmonde S; Edmonds A; Sudjaritruk T; Pinto J; Vreeman R; Dahourou DL; Twizere C; Kariminia A; Carlucci JG; Kasozi C; Davies MA;
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25780. PubMed ID: 34546646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
    Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
    J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population-based survey data.
    Glaubius R; Kothegal N; Birhanu S; Jonnalagadda S; Mahiane SG; Johnson LF; Brown T; Stover J; Mangal TD; Pantazis N; Eaton JW
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25784. PubMed ID: 34546644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
    Jewell BL; Mudimu E; Stover J; Ten Brink D; Phillips AN; Smith JA; Martin-Hughes R; Teng Y; Glaubius R; Mahiane SG; Bansi-Matharu L; Taramusi I; Chagoma N; Morrison M; Doherty M; Marsh K; Bershteyn A; Hallett TB; Kelly SL;
    Lancet HIV; 2020 Sep; 7(9):e629-e640. PubMed ID: 32771089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    Stover J; Brown T; Puckett R; Peerapatanapokin W
    AIDS; 2017 Apr; 31 Suppl 1():S5-S11. PubMed ID: 28296796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    Mahy M; Penazzato M; Ciaranello A; Mofenson L; Yianoutsos CT; Davies MA; Stover J
    AIDS; 2017 Apr; 31 Suppl 1(Suppl 1):S13-S22. PubMed ID: 28301337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds.
    Stover J; Johnson P; Zaba B; Zwahlen M; Dabis F; Ekpini RE
    Sex Transm Infect; 2008 Aug; 84 Suppl 1(Suppl_1):i24-i30. PubMed ID: 18647862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
    Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
    PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy.
    Mahy M; Lewden C; Brinkhof MW; Dabis F; Tassie JM; Souteyrand Y; Stover J
    Sex Transm Infect; 2010 Dec; 86 Suppl 2(Suppl_2):ii28-34. PubMed ID: 21106512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.
    GBD 2017 HIV collaborators
    Lancet HIV; 2019 Dec; 6(12):e831-e859. PubMed ID: 31439534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway.
    Whittaker R; Case KK; Nilsen Ø; Blystad H; Cowan S; Kløvstad H; van Sighem A
    BMC Infect Dis; 2020 Jun; 20(1):451. PubMed ID: 32590964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.